pyridoxal-5'-phosphate with and without ACE inhibitor

Phase 2

MEDICURE INC (MCUJF)

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

13 competitors in Diabetes Mellitus Type 2

LLYHuman Insulin Inhalation Powder

Phase 3

LLYInsulin lispro mix 25

Phase 3

NVOInsulin Glargine 100U/mL

Phase 3

View Full Landscape

Drug Information

Target Indication

Diabetes Mellitus Type 2

Clinical Trial

NCT00157729

Last updated: 2/13/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Source: FDA Orange Book

Drug Science

Mechanism of action & safety profile

Developer

MCUJF

MEDICURE INC

Pharmaceutical Preparations•North America•NASDAQ

Related Pipeline

(MC-1) Pyridoxal 5'-phosphatePhase 3

Coronary Artery Bypass Graft Surgery

Pyridoxal PhosphatePhase 3

Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency

Short TirofibanPhase 2

Myocardial Infarction

(MC-1) Pyridoxal-5'-phosphatePhase 2

Coronary Artery Bypass Graft Surgery

Long TirofibanPhase 2

Myocardial Infarction

View full pipeline

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts